Medivapom

Gabapentin, the active ingredient in Medivapom, is an anticonvulsant presented as an oral formulation for oral use. It treats epilepsy, postherpetic neuralgia, neuropathic pain and restless legs syndrome in adult patients.

GNH USA supplies Medivapom as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Gabapentin is employed across several neurological and pain‑related conditions, acting on the nervous system to reduce abnormal excitability. - Epilepsy: helps control partial seizures when added to other antiepileptic drugs. - Postherpetic neuralgia: alleviates persistent nerve pain following shingles. - Neuropathic pain: reduces chronic pain associated with diabetic or peripheral nerve injury. - Restless legs syndrome: diminishes uncomfortable leg sensations and urges to move, improving sleep quality.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Dizziness - Somnolence - Peripheral edema - Fatigue - Ataxia - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis, angioedema) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts or behavior - Respiratory depression when combined with CNS depressants - Hepatic failure - Blood dyscrasias such as agranulocytosis

Before initiating therapy, consider patient‑specific factors and safety measures. - Renal impairment: dose adjustment may be required due to renal excretion. - Pregnancy: use only if potential benefit justifies potential risk to the fetus. - Concomitant CNS depressants: monitor for enhanced sedation or respiratory depression. - Suicidality risk: observe for mood changes, especially in the early treatment phase. - Discontinue before surgery: stop at least 24 hours prior to elective procedures to reduce interaction with anesthetics. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Gabapentin may interact with several drug classes, influencing efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce gabapentin absorption. - Opioids: combined use can cause profound respiratory depression. - Strong CYP3A4 inducers (e.g., carbamazepine): may lower gabapentin plasma levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor renal function and potassium levels. - Diuretics: assess for increased risk of dizziness or hypotension. - NSAIDs: watch for additive central nervous system effects and renal considerations.